Read about Pfizer's approach to manufacturing excellence, likened  to a champion rowing team 

Read about Pfizer's approach to manufacturing excellence, likened  to a champion rowing team 

Read about Pfizer's approach to manufacturing excellence, likened  to a champion rowing team 

Making the complex
simple for highly
potent oral solid
dosage forms

Discover how successful CDMO collaboration sets the foundation for sterile injectable product success 

In this application note, we examine key considerations for the development and manufacturing of your unique sterile injectable

Discover how Pfizer CentreOne can help deliver high-quality sterile injectable therapeutics 

Unravel the complexities of ADC manufacturing in our whitepaper
 

Ready to meet your complex OSD needs, seamlessly and simply

Overcoming supply chain roadblocks to ensure reliable complex OSD delivery at Pfizer CentreOne, Ascoli 

Considerations for migrating a drug product presentation from a vial to pre-filled syringe 

What makes Pfizer CentreOne a CMO for therapies that define legacies?

Manufacturing services for therapies that define legacies

IP protection

Regulatory support

Fueling the progression of an innovative cystic fibrosis treatment with a complementary culture

Placing drug strategies on a solid foundation for success

How oral solid coating technologies can enhance delivery strategy - pharmaceutical online

Using exact SI-ence to unlock the potential of your sterile injectable

What does it take to navigate the future of OSD development?

Greener supply chains from a CMO powered by Pfizer

3 Trends shaping drug development and manufacturing strategies

Checklist: The commodities you’ll need when migrating a drug product presentation from vial to pre-filled syringe

Embracing pharma 5.0 for a patient-centered future

The essential steps in evaluating a pre-filled syringe system

Five best practices to ensure quality active pharmaceutical ingredients

Liposomes – challenges and opportunities

Making a case for a fixed dose combination drug strategy

Assuring drug substance and product supply chains to support worldwide delivery of Sobi’s life-saving biologic

Case study | How intelligent collaboration transformed a generic into a best-in-class new drug

Driving the seamless tech transfer of multiple projects within a condensed timeline

Ensuring reliable complex OSD delivery in the face of natural disaster at Pfizer CentreOne, Newbridge

A beginner’s guide to technology transfers

Highly potent oral solids: challenges and considerations | Webinar

Overcoming supply chain and logistics challenges with Pfizer CentreOne

Streamline your technology transfer

Pfizer CentreOne's regulatory affairs team named a finalist of CPhI excellence in pharma awards

Pfizer opens €300 million state-of-the-art drug manufacturing site in Freiburg, Germany

Making the complex simple for OSD manufacturing and packaging

Making the complex, Simple: A roadmap for your OSD journey

Overcome your sterile injectable challenges with the exact SI-ence of Pfizer

Technology transfer in sterile injectables - three phases towards success | Webinar

Unlocking the potential of your sterile injectables with exact SI-ence

Helping you navigate the evolving antibody therapeutic landscape

Liposomal and Nanoparticle technology at Pfizer Melbourne

Pfizer experts are ready to help meet your complex OSD needs from our site in Ascoli, Italy

Migrating a drug product presentation from vial to prefilled syringe - On drug delivery

Making the move: migrating a drug product from vial to prefilled syringe

Into a post-COVID world: Overcoming pharmaceutical supply chain challenges and unlocking CDMO opportunities

Prefilled syringe vs glass vial processing: What's the Difference?

Putting contract dose manufacturing trends under the spotlight

Understanding the evolving trends in the complex biologics landscape

Uniting target product profile, regulatory partnering strategies are essential for sustainable product success

What are the key trends and developments in injectable drug formulation and delivery?

Enviero progesterone: Pfizer CentreOne’s green-chemistry progesterone API

Freiburg Site Spotlight

The future of innovative antibody therapeutics

General capabilities

Global quality operations Pfizer quality standards (PQS)

McPherson site spotlight

Pearl River site spotlight

Unraveling ADC complexities with bio-logic brilliance

Building more resilient API supply chains

Culture of confidentiality: Our promise to sustomers

Making the complex. Simple.

Making the medicine go down: Specialized oral solids delivery technologies

Picking the perfect API partner

Quality attributes for strategic small molecule API partners

Starting your sterile injectables program off on the right foot

Sterile injectables supply on demand

Taking care of your API: What to ask your CDMO

Three good reasons why an integrated CDMO model offers the best route to success

The three key ingredients to a successful API project

Top four considerations for tech transfer performance

Unlock the future of OSD manufacturing

Why the right partner is key to successful drug innovation

Your questions answered - Highly potent oral solids Q&A

Your questions answered - Technology transfer in sterile injectables

Celebrating excellence: Pfizer CentreOne wins the CDMO leadership awards 2024

CMO leadership awards 2022: Pfizer CentreOne wins for sixth consecutive year

CPhI discover: Embedding responsible manufacturing practices across the pharmaceutical value chain

Fifth consecutive CMO Leadership award demonstrates our continued commitment to being a partner of choice

Harnessing the power of virtual audits to keep regulatory compliance front and center

International Women's Day

Pfizer CenterOne’s Enviero® receives first EU authorization as part of ESTIMA® (progesterone) product approval

Pfizer CentreOne enters the ring with vibrant new API & Intermediates campaign

Pfizer CentreOne wins CMO leadership award for fifth consecutive year

Pfizer CentreOne wins medicine maker CDMO of the Year award